INVO INVO BioScience, Inc.

INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.

As of 11/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  11/11/2008
Outstanding shares:  11,734,772
Average volume:  41,774
Market cap:   $35,086,968
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    44984F302
ISIN:        US44984F3029
Valuation   (See tab for details)
PE ratio:   -3.34
PB ratio:   11.85
PS ratio:   42.76
Return on equity:   -450.01%
Net income %:   -1,423.10%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy